Arcus Biosciences Announces New Employment Inducement GrantsBusiness Wire • 17 days ago
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today...
Share to Feed
Arcus Biosciences, Inc. (NYSE:RCUS - Get Free Report)'s stock price fell 2.8% during mid-day trading on Wednesday . The company traded as low as $17.14 and last traded at $17.23. 14,247 shares...
This is a signal that RCUS's price trend could be reversing, and it may be an opportunity to sell the stock or take a defensive position...
This indicator may be signaling that RCUS's price has further to drop, since it moved below its price 14 days ago. Traders may consider selling the stock, shorting the stock, or exploring put options...
This is a Bullish indicator signaling RCUS's price could rise from here. Traders may explore going long the stock or buying call options...
Related Stocks: RCUS...
This price move could indicate a change in the trend, and may be a buy signal for investors...
This is a signal that RCUS's price trend could be reversing, and it may be an opportunity to buy the stock or explore call options...
Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for people with cancer, today...
Latest Ratings for RCUS
DateFirmActionFromTo Nov 2021CitigroupMaintainsBuy Nov 2021BarclaysMaintainsOverweight Nov 2021SVB LeerinkMaintainsOutperform
View More Analyst Ratings for RCUS...